Search Results - Olga Sala‐Torra

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Precision Medicine in Low- and Middle-Income Countries

    Precision Medicine in Low- and Middle-Income Countries by Jerald P. Radich, Edward L. Briercheck, Daniel T. Chiu, Manoj Menon, Olga Sala‐Torra, Cecilia C.S. Yeung, Edus H. Warren

    Published 2022
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    IL-6 Controls Leukemic Multipotent Progenitor Cell Fate and Contributes to Chronic Myelogenous Leukemia Development

    IL-6 Controls Leukemic Multipotent Progenitor Cell Fate and Contributes to Chronic Myelogenous Leukemia Development by Damien Reynaud, Eric M. Pietras, Keegan Barry-Holson, Alain Mir, Mikhail Binnewies, Marion Jeanne, Olga Sala‐Torra, Jerald P. Radich, Emmanuelle Passegué

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients

    Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients by Olga Sala‐Torra, Megan Othus, David Williamson, Brent L. Wood, Ilan R. Kirsch, Harlan Robins, Lan Beppu, Margaret O’Donnell, Stephen J. Forman, Frederick R. Appelbaum, Jerald P. Radich

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia

    Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia by Anjali S. Advani, Holly Gundacker, Olga Sala‐Torra, Jerald P. Radich, Raymond Lai, Marilyn L. Slovak, Jeffrey E. Lancet, Steven Coutré, Robert K. Stuart, Martha P. Mims, Patrick J. Stiff, Frederick R. Appelbaum

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Evidence of Donor-Derived Hematologic Malignancies after Hematopoietic Stem Cell Transplantation

    Evidence of Donor-Derived Hematologic Malignancies after Hematopoietic Stem Cell Transplantation by Olga Sala‐Torra, Colleen Hanna, Michael R. Loken, Mary E.D. Flowers, Michael B. Maris, Paula Ladne, James R. Mason, David Senitzer, Roberto Rodríguez, Stephen J. Forman, H. Joachim Deeg, Jerald P. Radich

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    DDX3Y encodes a class I MHC–restricted H-Y antigen that is expressed in leukemic stem cells

    DDX3Y encodes a class I MHC–restricted H-Y antigen that is expressed in leukemic stem cells by Kellie V. Rosinski, Nobuharu Fujii, Jeffrey K. Mito, Kevin K. W. Koo, Suzanne M. Xuereb, Olga Sala‐Torra, James S. Gibbs, Jerald P. Radich, Yoshiki Akatsuka, Benoı̂t J. Van den Eynde, Stanley R. Riddell, Edus H. Warren

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: